Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Plasmodium falciparum | conserved Plasmodium protein, unknown function | 0.0058 | 0.0975 | 1 |
Trypanosoma cruzi | UDP-galactopyranose mutase | 0.0058 | 0.0975 | 0.5 |
Echinococcus multilocularis | lysine specific demethylase 5A | 0.0037 | 0.0233 | 0.0255 |
Mycobacterium ulcerans | flavin-containing monoamine oxidase AofH | 0.0058 | 0.0975 | 0.5 |
Leishmania major | UDP-galactopyranose mutase | 0.0058 | 0.0975 | 0.5 |
Loa Loa (eye worm) | jmjC domain-containing protein | 0.0063 | 0.1177 | 0.1177 |
Loa Loa (eye worm) | hypothetical protein | 0.0283 | 0.9134 | 0.9134 |
Onchocerca volvulus | 0.0307 | 1 | 1 | |
Mycobacterium ulcerans | oxidoreductase | 0.0058 | 0.0975 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0052 | 0.079 | 0.079 |
Mycobacterium leprae | PROBABLE PROTOPORPHYRINOGEN OXIDASE HEMY (PROTOPORPHYRINOGEN-IX OXIDASE) (PROTOPORPHYRINOGENASE) (PPO) | 0.0058 | 0.0975 | 0.5 |
Schistosoma mansoni | Protoporphyrinogen oxidase chloroplast/mitochondrial precursor | 0.0058 | 0.0975 | 0.1067 |
Mycobacterium ulcerans | flavin-containing monoamine oxidase AofH | 0.0058 | 0.0975 | 0.5 |
Giardia lamblia | PHD finger protein 15 | 0.0031 | 0 | 0.5 |
Echinococcus multilocularis | 0.0058 | 0.0975 | 0.1067 | |
Schistosoma mansoni | jumonji/arid domain-containing protein | 0.0037 | 0.0233 | 0.0255 |
Loa Loa (eye worm) | hypothetical protein | 0.0307 | 1 | 1 |
Toxoplasma gondii | histone lysine-specific demethylase LSD1/BHC110/KDMA1A | 0.0058 | 0.0975 | 1 |
Echinococcus multilocularis | Transcription factor, JmjC domain containing protein | 0.01 | 0.2516 | 0.2755 |
Mycobacterium ulcerans | protoporphyrinogen oxidase | 0.0058 | 0.0975 | 0.5 |
Mycobacterium tuberculosis | Possible oxidoreductase | 0.0058 | 0.0975 | 0.5 |
Toxoplasma gondii | histone lysine-specific demethylase | 0.0058 | 0.0975 | 1 |
Schistosoma mansoni | jumonji/arid domain-containing protein | 0.0037 | 0.0233 | 0.0255 |
Plasmodium falciparum | lysine-specific histone demethylase 1, putative | 0.0058 | 0.0975 | 1 |
Echinococcus granulosus | lysine specific histone demethylase 1A | 0.0283 | 0.9134 | 1 |
Echinococcus granulosus | Transcription factor JmjC domain containing protein | 0.01 | 0.2516 | 0.2755 |
Brugia malayi | jmjC domain containing protein | 0.0037 | 0.0233 | 0.0233 |
Chlamydia trachomatis | protoporphyrinogen oxidase | 0.0058 | 0.0975 | 0.5 |
Brugia malayi | amine oxidase, flavin-containing family protein | 0.0082 | 0.1841 | 0.1841 |
Plasmodium falciparum | protoporphyrinogen oxidase | 0.0058 | 0.0975 | 1 |
Brugia malayi | hypothetical protein | 0.0058 | 0.0975 | 0.0975 |
Echinococcus granulosus | jumonji domain containing protein | 0.0043 | 0.0433 | 0.0474 |
Echinococcus multilocularis | protoporphyrinogen oxidase | 0.0058 | 0.0975 | 0.1067 |
Plasmodium vivax | lysine-specific histone demethylase 1, putative | 0.0058 | 0.0975 | 1 |
Schistosoma mansoni | Lysine-specific histone demethylase 1 | 0.0283 | 0.9134 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0058 | 0.0975 | 0.0975 |
Trypanosoma cruzi | UDP-galactopyranose mutase | 0.0058 | 0.0975 | 0.5 |
Plasmodium vivax | hypothetical protein, conserved | 0.0058 | 0.0975 | 1 |
Schistosoma mansoni | jumonji domain containing protein | 0.008 | 0.1772 | 0.194 |
Loa Loa (eye worm) | hypothetical protein | 0.0082 | 0.1841 | 0.1841 |
Loa Loa (eye worm) | hypothetical protein | 0.0283 | 0.9134 | 0.9134 |
Loa Loa (eye worm) | jmjC domain-containing protein | 0.0037 | 0.0233 | 0.0233 |
Echinococcus multilocularis | lysine specific histone demethylase 1A | 0.0283 | 0.9134 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0058 | 0.0975 | 0.0975 |
Mycobacterium ulcerans | monoamine oxidase | 0.0058 | 0.0975 | 0.5 |
Mycobacterium ulcerans | dehydrogenase | 0.0058 | 0.0975 | 0.5 |
Schistosoma mansoni | amine oxidase | 0.0058 | 0.0975 | 0.1067 |
Brugia malayi | jmjC domain containing protein | 0.01 | 0.2516 | 0.2516 |
Echinococcus multilocularis | jumonji domain containing protein | 0.0043 | 0.0433 | 0.0474 |
Plasmodium vivax | protoporphyrinogen oxidase, putative | 0.0058 | 0.0975 | 1 |
Echinococcus granulosus | lysine specific demethylase 5A | 0.0037 | 0.0233 | 0.0255 |
Echinococcus granulosus | lysine specific histone demethylase 1A | 0.0058 | 0.0975 | 0.1067 |
Schistosoma mansoni | amine oxidase | 0.0058 | 0.0975 | 0.1067 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0058 | 0.0975 | 0.5 |
Plasmodium vivax | hypothetical protein, conserved | 0.0058 | 0.0975 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | = 2.3 uM | PUBCHEM_BIOASSAY: SAR Analysis of small molecule inhibitors of T-cell specific antigen receptor-induced NF-kB activation in a HEK-293T cell line using a luminescence assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID435003, AID435012, AID489026] | ChEMBL. | No reference |
IC50 (functional) | = 2.52 uM | PUBCHEM_BIOASSAY: SAR Analysis of small molecule inhibitors of T-cell specific antigen receptor-induced NF-kB activation in a Jurkat cell line using a luminescence assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID435003, AID435012, AID465] | ChEMBL. | No reference |
IC50 (functional) | = 22.5 uM | PUBCHEM_BIOASSAY: SAR analysis of small molecule cytotoxicity in HEK293 cells for activators of NF-kappaB using a luminescence assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID435003, AID435012, AID435022, AID435025] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.